drugset / Trial / NCT06449131

Persistent Pleural Effusion Treatment Following Cardiothoracic Surgery by Platelet-Fibrin Glue

NCT06449131

Phase 2 Completed 19 enrolled Daryoush Hamidi Alamdari, PhD
NaSingle-groupOpen-labelTreatment

Summary

Persistent pleural effusion is a life-threatening complication after cardiac surgery. The traditional treatment is chest tube drainage, which may not respond to treatment. This study introduces a new noninvasive approach for treating persistent pleural effusion using platelet-rich plasma fibrin glue (PRP-FG). This method has been successfully applied for the treatment of postoperative persistent chylothorax and pneumothorax in previous studies, which significantly decreased morbidity, mortality, and hospital stay.

Timeline

Start
2017-05-01
Primary completion
2023-05-01
Completion
2024-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified

Indications

No indication recorded.